FOURTH QUARTER 2017 INVESTOR PRESENTATION
February 22, 2018
Financing the Growth of Tomorrow’s Companies Today
TM
FOURTH QUARTER 2017 INVESTOR PRESENTATION Financing the Growth of - - PowerPoint PPT Presentation
February 22, 2018 FOURTH QUARTER 2017 INVESTOR PRESENTATION Financing the Growth of Tomorrows Companies Today TM IMPORTANT NOTICE: FORWARD LOOKING STATEMENTS This presentation may contain forward -looking statements within the meaning
February 22, 2018
Financing the Growth of Tomorrow’s Companies Today
TM
This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act
21E(b)(2)(B) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 do not apply to forward-looking statements made in periodic reports we file under the Exchange Act. The information disclosed in this presentation is made as
the date hereof and reflects Hercules’ current assessment of its financial performance for the period reported. Actual financial results filed with the Securities and Exchange Commission in the future may differ from those contained herein in the event of additional adjustments recorded prior to the filing of its financial statements. This presentation may contain “forward-looking statements.” These forward-looking statements include comments with respect to our financial objectives, loan portfolio growth, strategies and results of our operations. However, by their nature, these forward-looking statements involve numerous assumptions, uncertainties and risks, both general and specific. The risk exists that these statements may not be fulfilled. We caution readers of this presentation not to place undue reliance on these forward-looking statements as a number of factors could cause future Company results to differ materially from these statements. Forward-looking statements may be influenced in particular by factors such as fluctuations in interest rates and stock indices, the effects of competition in the areas in which we operate, and changes in economic, political and regulatory conditions. We caution that the foregoing list is not exhaustive. When relying on forward-looking statements to make decisions, investors should carefully consider the aforementioned factors as well as other uncertainties and events. Historical results discussed in this presentation are not indicative of future results. This presentation should be read in conjunction with our recent SEC filings.
2
February 22, 2018
Company & Strategic Overview Financial Highlights Portfolio Highlights Venture Capital Market Opportunity Analyst Coverage Key Performance Highlights Supplemental Information
5
(1) Excludes one-time impact of $2.4M or $0.03 per share associated with the $75.0M 2024 Notes redemption plus the non-recurring interest overlap due to the 30-day notice redemption period (2) Based on NII, excludes realized and unrealized gains/losses (3) Net regulatory leverage is defined as regulatory leverage less cash balance at period end (4) As of February 20, 2018 (5) Source: S&P CapIQ as of 12/31/17
Robust Earnings
Strong Shareholder Returns
High-Yield Portfolio of Earning Assets
Industry-Leading Originations Platform
Strong Liquidity and Balance Sheet
Strong Capital Raising Position
1.8% 165.8% 222.8% 96.3% 0.9% 62.4% 101.1% 125.9% 0.1% 28.1% N/A N/A
0% 20% 40% 60% 80% 100% 120% 140% 160% 180% 200% 220% 240% 1- Year 5-Year 7-Year 10-Year HTGC Peer Group WF BDCS (3/31/16)
6 (a) Peer Group: AINV, ARCC, BKCC, OCSL, FSIC, GBDC, GSBD, KCAP, MAIN, MCC, NMFC, PNNT, PSEC, SLRC, TCAP, TCPC, TCRD, TICC,TSLX (b) TSR is defined as stock appreciation plus distributed dividend distributions Source: S&P Capital IQ as of December 31, 2017
(a)
(b)
$0.33 $1.23 $2.43 $3.75 $5.01 $5.81 $6.69 $7.64 $8.75 $9.99 $11.23 $12.47 $13.71 $14.02
$0 $5 $10 $15
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Q1 2018 Cumulative Distributions Declared (per Share) $14.02 per share or ~$702 million in Historical Cumulative Distributions Since June 2005 IPO 2018 YTD Distributions Paid: $0.31
12.9% 10.1% 11.7% 12.6% 12.0% 11.0% 10.8% 11.0% 9.6% 8.6%
0% 2% 4% 6% 8% 10% 12% 14% 2013 2014 2015 2016 Q4 2017
HTGC Peer Group
6.4% 5.2% 6.1% 7.2% 6.3% 6.9% 6.5% 6.0% 5.7% 5.4%
0% 1% 2% 3% 4% 5% 6% 7% 8% 2013 2014 2015 2016 Q4 2017
HTGC Peer Group
Return on Average Assets % (ROAA)
7
Return on Average Equity % (ROAE)
(a) Peer Group: AINV, ARCC, BKCC, OCSL, FSIC, GBDC, GSBD, KCAP, MAIN, MCC, NMFC, PNNT, PSEC, SLRC, TCAP, TCPC, TCRD, TICC,TSLX
(a) (a)
Source: S&P Capital IQ as of 9/30/17 for Peer Group and 12/31/17 for HTGC. Return on Average Assets excluding cash. NII divided by average of beginning of period total assets excluding cash and end of period total assets excluding cash. Source: S&P Capital IQ as of 9/30/17 for Peer Group and 12/31/17 for HTGC. Return on Average Equity based
(1) Q1 09 distribution was paid in 10% cash and 90% stock; (2) Includes special $0.04 distribution paid in December 2009 (2) Note: The Yield Calculation may include a potential tax return of capital. Any portion of a distribution that is ultimately deemed to be a tax return of capital should not be considered. The determination of the tax attributes of the Company's distributions is made annually as of the end of the Company's fiscal year based upon its taxable income for the full year and distributions paid for the full year. Therefore, a determination made on a quarterly basis may not be representative of the actual tax attributes of its distributions for a full year. The tax attributes of its distributions for the years ended December 31, 2008 through December 31., 2017 were paid 100% from earnings and profits; however, there can be no certainty to shareholders that this determination is representative of what the tax attributes of its 2017 distributions to shareholders will actually be.
(1, 2)
$9.75 $10.51 $10.18 $9.94 $9.90 $9.96 1.14 1.56 1.46 1.23 1.43 1.32 1.07 1.07 0.92 0.92 0.96 0.94
0.5 0.7 0.9 1.1 1.3 1.5 1.7
2012 2013 2014 2015 2016 Q4 2017
$8 $10 $12 $14 $16
Hercules NAV Hercules Price to NAV Peer Group Price to NAV
(a) Peer Group: AINV, ARCC, BKCC, OCSL, FSIC, GBDC, GSBD, KCAP, MAIN, MCC, NMFC, PNNT, PSEC, SLRC, TCAP, TCPC, TCRD, TICC,TSL Note: Source S&P CapIQ as of September 30, 2017 for Peer Group and December 31, 2017 for HTGC. Stock price based on closing price on last trading day of each calendar year or relative quarter.
(a)
8
Price to NAV
CREATES A STRONG CAPITAL RAISING POSITION TO SUPPORT GROWTH
$747.4 $1,123.6 $1,221.7 $1,299.2 $1,324.0 $1,464.2 $1,654.7
$100 $300 $500 $700 $900 $1,100 $1,300 $1,500 $1,700
2011 2012 2013 2014 2015 2016 2017
$39.6 $48.1 $73.1 $71.8 $73.5 $100.3 $96.4 $0 $20 $40 $60 $80 $100
2011 2012 2013 2014 2015 2016 2017
Net Investment Income “NII”
($ in millions)
9
$79.9 $97.5 $139.7 $143.7 $157.1 $175.1 $190.9 $0 $20 $40 $60 $80 $100 $120 $140 $160 $180 $200
2011 2012 2013 2014 2015 2016 2017
Total Investment Income
($ in millions)
Total Assets
($ in millions)
$587.4 $914.3 $906.3 $1,035.3 $1,252.3 $1,511.5 $1,619.8
$100 $300 $500 $700 $900 $1,100 $1,300 $1,500 $1,700
2011 2012 2013 2014 2015 2016 2017
Total Investments at Cost
($ in millions)
(a) Amount includes the one-time benefit of a litigation settlement of $8.0 million
(a)
Cumulative Total Aggregate Net Realized Gains/(Losses), Since Inception 12/03
($50.1) ($50.1) ($47.0) ($32.1) ($12.0) ($6.9) ($39.9) $3.1 $14.9 $20.1 $5.1 $4.6 $10.9
($50.1) ($47.0) ($32.1) ($12.0) ($6.9) ($2.3) ($29.0)
$0 $10 $20 $30
2011 2012 2013 2014 2015 2016 2017
Net Realized Gains Net Realized Loss Carry Forward Cumulative Net Realized Loss, Since Inception 12/03
$ in millions $0.2 $0.5 $0.9 $1.4 $1.5 $2.1 $2.7 $3.4 $4.0 $4.9 $5.7 $6.5 $7.3 $0.2 $0.4 $0.7 $1.1 $1.2 $1.5 $1.9 $2.4 $2.9 $3.5 $4.2 $4.9 $5.6 $0.0 $1.0 $2.0 $3.0 $4.0 $5.0 $6.0 $7.0 $8.0 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Cumulative Commitments Cumulative Fundings $ in billions
Cumulative Debt Commitment and Fundings, Since Inception 12/03
10
HTGC IPO
Illustration: A growing debt investment portfolio provides potential for future increased dividend payout(1)
PORTFOLIO GROWTH LEADS TO DIVIDEND COVERAGE GROWTH THROUGH NII
(1) Debt Investment portfolio at $1.4 billion, at cost, as of December 31, 2017. Assumes constant effective yield, NII margin of 52.0% and constant weighted average shares of 83.8
$1,400 $1,500 $1,600 $1,700 $1.06 $1.14 $1.21 $1.29 $1.23 $1.32 $1.41 $1.50
$1.00 $1.10 $1.20 $1.30 $1.40 $1.50 $1.60 $1.70 $1.80 $1.90 $2.00 $0 $200 $400 $600 $800 $1,000 $1,200 $1,400 $1,600 $1,800 $2,000 + $0 Million + $100 Million + $200 Million + $300 Million NII per share Debt Investment Balance at Cost ($ in millions)
Debt Investment Portfolio Balance at Cost NII P/S @ Core Yield of 12.2% NII P/S @ Effective Yield of 14.2%
11
$3,152
$6,368 $9,605 $12,937 $26,683 $40,322
+0.04 +0.08 +0.11 +0.15 +0.32 +0.48
0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50 $0 $5,000 $10,000 $15,000 $20,000 $25,000 $30,000 $35,000 $40,000 $45,000
25 50 75 100 200 300
Earning per Share(1) Net Income ($ in thousands) Basis Point Increase in Prime Rate
Net Income EPS
We anticipate each 25 bps, or 0.25%, increase in the Prime Rate to contribute ~$3.2 million to Net Interest Income, or $0.04 per share annually
RISING INTEREST RATES & HIGH ASSET SENSITIVITY WILL BENEFIT HERCULES SIGNIFICANTLY
(1) EPS calculated on basic weighted shares outstanding of 83.8 million as of December 31, 2017. Estimates are subject to change due to impact from active participation in the Company’s equity ATM program. 12
WARRANT & EQUITY PORTFOLIO
WARRANT HOLDINGS IN
137 Companies
WARRANT GAAP FAIR VALUE
$36.8 million
WARRANT GAAP COST
$43.6 million
EQUITY HOLDINGS IN
52 Companies
EQUITY GAAP FAIR VALUE
$89.4 million
EQUITY GAAP COST
$136.2 million
137
COMPANIES
LIQUIDITY & BALANCE SHEET
AVAILABLE LIQUIDITY TO INVEST(2)
$286.3 million
REGULATORY LEVERAGE
72.9% / 62.0% net of cash
ADDITIONAL DEBT CAPACITY
$228.3 million
INVESTMENT GRADE RATINGS
S&P: BBB- KBRA: BBB+
SECURITIZATION INVESTMENT GRADE RATINGS
KBRA: A(sf)
$286.3
MILLION
DEBT INVESTMENT PORTFOLIO
DEBT INVESTMENT COST BASIS
$1.44 billion
DEBT INVESTMENT FAIR VALUE
$1.42 billion
EFFECTIVE YIELD
14.2%
DEBT INVESTMENTS IN
85 Companies
SHORT TERM MATURITIES
36-42 months
INVESTMENT SIZE
$5 TO $100 MILLION
$1.44
BILLION
14
MARKET CAPITALIZATION
FOUNDED DECEMBER 2003
IPO: June 2005 “HTGC”
ENTERPRISE VALUE
$1.6 billion(1)
MARKET CAPITALIZATION
$1.05 billion(1)
NET ASSET VALUE PER SHARE
$9.96 as of 12/31/17
HISTORICAL PRICE/NAV
~1.3x to ~1.6x range
CURRENT PRICE/NAV
1.24x(1)
$1.05
BILLION
(1) As of February 20, 2018 (2) Subject to existing terms and covenants
LARGEST BUSINESS DEVELOPMENT COMPANY (BDC) FOCUSED ON PROVIDING FINANCING TO HIGH-GROWTH VENTURE CAPITAL-BACKED COMPANIES
What We Don’t Do and What We Are Not
▪ No oil and gas exposure ▪ No CLO exposure ▪ No CMBS or RMBS exposure ▪ No metals or minerals exposure
What We Do
▪ We focus primarily on pre-IPO and M&A, innovative high-growth venture capital backed companies at their
expansion (venture growth) and established stages in a broadly diversified variety of technology, life sciences and sustainable and renewable technology industries
▪ Highly asset sensitive debt investment portfolio – 96.4% floating rate loans and with interest rate floors(1) ▪ We are generally the only lender and 79.9% are "true" first lien senior secured(1) ▪ Substantially all of our debt investments include warrants for potential additional total return ▪ Substantially all of our debt investments have short term amortizing maturities (36-42 months) ▪ Focused on strong and sustainable shareholder returns ▪ Disciplined, proven investment philosophy with 14 years of strong credit performance history
(1) As of December 31, 2017 15
WE INVEST IN INNOVATIVE VENTURE GROWTH-STAGE COMPANIES
Hercules’ At-the-Market “ATM” Equity and Debt Distribution Agreements
▪ Equity Distribution Agreement: Up to a total of 12 million shares of common stock ▪ Debt Distribution Agreement: Up to $150.0 million of 6.25% Notes due 2024
The Benefits and Competitive Advantages
▪ “Just-in-Time” access provides control on the timing, pricing and amount of capital raised, with full
control over leverage ratios
▪ Ideal for raising growth capital when needed, proceeds expeditiously invested in new investments ▪ Exceptionally low and cost effective access to capital markets ▪ Equity issuances are highly accretive to NAV; HTGC trades at a significant premium to NAV
The Results
▪ Equity ATM Capital Program 2017: sold ~4.9 million shares for total net proceeds of ~ $66.9 million ▪ Debt ATM Capital Program 2017: sold 225,457 notes in aggregate principal amount of ~ $5.6 million
16
HERCULES’ SUCCESSFUL ATM DISTRIBUTION PROGRAMS
17
Technology Life Sciences Sustainable and Renewable Technology Special Situations
We Invest at the Expansion “Venture Growth” and Established Stage
HERCULES HAS DOMAIN EXPERTISE IN FOUR SPECIALIZED LENDING GROUPS “WE ARE NOT GENERALISTS”
Over $7.3 billion in total debt commitments to over 410 companies since inception Offices in key venture capital markets: CA | MA | NY | DC | IL | CT Over 1000 different VC & PE firms, financial investors Over 130 portfolio companies completed/announced an IPO or M&A event since inception
(1)
19
Interest Income $ 46,394 $ 42,680 9% Fee Income 3,804 4,792
Total Investment Income 50,198 47,472 6% Interest and Loan Fees 13,039 10,055 30% General and Administrative 3,744 4,010
Employee Compensation 8,897 8,290 7% Total Operating Expenses 25,680 22,355 15% Other Income 8,000 Pre-Tax Net Investment Income-NII 24,518 33,117
Net Realized and Unrealized Gain / (Loss) (6,152) (18,996)
Net Increase in Net Assets from Operations 18,366 14,121 30% NII - Net Investment Income per Share (Basic) $ 0.29 $ 0.43
Adjusted NII $ 0.32 $ 0.33 DNOI - Distributable Net Operating Income per Share $ 0.31 $ 0.45
Adjusted DNOI $ 0.34 $ 0.35 Weighted Average Shares Outstanding - Basic 83,843 76,931 9% Three Months Ended December 31,
(1)
(1) Excludes the one-time impact of $2.4 million, of $0.03 per share associated with the $75.0 million 2024 Notes redemption plus the non-recurring interest overlap due to the 30-day notice redemption (2) Amount excludes the one-time benefit of a litigation settlement of $8.0 million.
(2) (2)
(1) (1)
20
Twelve Months Ended December 31, ($ in 000's, except per share amounts) 2017 2016 2015 2014 Interest Income $ 172,196 $ 158,727 $ 140,266 $ 126,618 Fee Income 18,684 16,324 16,866 17,047 Total Investment Income 190,880 175,051 157,132 143,665 Interest and Loan Fees 46,585 37,058 36,889 33,390 General and Administrative 16,105 16,106 16,658 10,209 Employee Compensation 31,746 29,543 30,083 26,165 Total Operating Expenses 94,436 82,707 86,630 70,334 Other Income
(1)
96,444 100,344 73,501 71,750 Net Realized and Unrealized Gain / (Loss) (17,446) (31,641) (30,585) (562) Net Increase in Net Assets from Operations $ 78,998 $ 68,703 $ 42,916 $ 71,188 NII - Net Investment Income per Share (Basic) $ 1.16 $ 1.34 $ 1.04 $ 1.13 Adjusted NII $ 1.22 $ 1.24 DNOI - Distributable Net Operating Income per Share $ 1.26 $ 1.45 $ 1.19 $ 1.31 Adjusted DNOI $ 1.32 $ 1.35 Weighted Average Shares Outstanding - Basic 82,519 73,753 69,479 61,862
(1) Excludes the one-time impact of $2.4 million, of $0.03 per share associated with the $75.0 million 2024 Notes redemption and the one-time impact of $2.1 million, or $0.03 per share associated with the $110.4 million 2019 Notes redemption, plus the non-recurring interest overlap due to the 30-day notice redemption for both (2) Amount excludes the one-time benefit of a litigation settlement of $8.0 million.
(2) (2)
($ in 000's, except per share amounts) 2017 2016 2015 2014 ASSETS
Investments $ 1,542,214 $ 1,423,942 $ 1,200,638 $ 1,020,737 Cash and cash equivalents 91,309 13,044 95,196 227,116 Restricted cash 3,686 8,322 9,191 12,660 Interest receivable 12,262 11,614 9,239 9,453 Other assets 5,244 7,282 9,720 13,774
Total Assets
$ 1,654,715 $ 1,464,204 $ 1,323,984 $ 1,283,740
LIABILITIES
Accounts Payable and Accrued Liabilites 26,896 21,463 17,241 14,101 Credit Facilities
50,000
223,488
17,170 2021 Asset-Backed Notes 48,650 107,972 126,995 126,093 2019 Notes
108,179 166,012 2024 Notes 179,001 245,490 100,128 99,795 Long-term SBA Debentures 188,141 187,501 186,829 186,162 2022 Notes 147,572
Total Liabilites
$ 813,748 $ 676,260 $ 606,850 $ 624,876
Net Assets
$ 840,967 $ 787,944 $ 717,134 $ 658,864 Shares Outstanding 84,424 79,555 72,118 64,715
Net Assets per Share
$ 9.96 $ 9.90 $ 9.94 $ 10.18
December 31,
21
16.9% 16.7% 16.0% 12.9% 13.8% 16.4% 14.2% 13.2% 14.4% 14.6% 14.4% 13.4% 14.9% 14.1% 14.2% 13.9% 13.8% 13.0% 12.8% 13.2% 12.6% 13.3% 12.9% 13.4% 13.2% 12.9% 12.2% 12.1% 12.6% 12.5% 10.6% 10.7% 10.3% 10.2% 9.8% 9.4% 9.2% 9.1% 9.2% 9.2% 9.2% 8.9% 9.3% 9.6% 9.8% 6% 8% 10% 12% 14% 16% 18% 20%
Q2-14 Q3-14 Q4-14 Q1-15 Q2-15 Q3-15 Q4-15 Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17
Effective Yield
GAAP Effective Yield Core Yield Loan Coupon Rate
(1) Effective Yield is inclusive of all fees, including all realized unamortized fees and all realized transaction fees including but not limited to amendment fees and prepayment fees, and is calculated based on the weighted average principal balance of loans outstanding on a daily basis (2) Core Yield excludes Early Repayments and One-Time Fees, and includes income and fees from expired commitments (2) 22
MEDIAN CORE YIELD FROM Q2 2014 TO Q4 2017: 12.9%
(1)
$898.0 $907.9
$923.9 $1,058.0 $1,137.6 $1,077.6 $1,110.2 $1,205.7 $1,211.8 $1,224.1 $1,328.8 $1,311.9 $1,287.6 $1,300.1 $1,416.0
16.9% 16.7% 16.0% 12.9% 13.8% 16.4% 14.2% 13.2% 14.4% 14.6% 14.4% 13.4% 14.9% 14.1% 14.2% 0.0% 2.0% 4.0% 6.0% 8.0% 10.0% 12.0% 14.0% 16.0% 18.0%
$100 $300 $500 $700 $900 $1,100 $1,300 $1,500 $1,700 $1,900
Effective Yield (%) Total Debt Investments, at value (millions)
Total Debt Investments at fair value Effective Yield
(1)
23
MEDIAN EFFECTIVE YIELD FROM Q2 2014 TO Q4 2017 OF 14.4%
(1) Effective Yield is inclusive of all fees, including all realized unamortized fees and all realized transaction fees including but not limited to amendment fees and prepayment fees, and is calculated based
$26,376 $28,137 $27,065 $23,127 $28,974 $38,242 $29,900 $30,933 $34,688 $34,953 $37,418 $33,920 $37,850 $35,366 $37,159
10.1% 10.4% 9.7% 8.2% 10.2% 13.4% 10.2% 10.1% 11.0% 11.1% 11.8% 10.1% 11.1% 10.4% 10.4% 0% 3% 6% 9% 12% 15% 18% 21% Q2-14 Q3-14 Q4-14 Q1-15 Q2-15 Q3-15 Q4-15 Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2 -17 Q3-17 Q4-17 $0 $5,000 $10,000 $15,000 $20,000 $25,000 $30,000 $35,000 $40,000
Net Interest Margin % Net Interest Margin (in thousands)
Net Interest Margin ($) Net Interest Margin (%)
(1) Net Interest Margin = Net Interest Income/Average Yielding Assets excluding Equity Investments 24
(1)
EFFECTIVE YIELDS
Early Payoffs Lead to Higher Effective Yields and Earnings
UNSCHEDULED EARLY PAYOFFS -$1.58 BILLION FROM Q1 2014-TO-Q4 2017 ($ in millions)
1 25
16.9% 16.7% 16.0% 12.9% 13.8% 16.4% 14.2% 13.2% 14.4% 14.6% 14.4% 13.4% 14.9% 14.1% 14.2% 13.9% 13.8% 13.0% 12.8% 13.2% 12.6% 13.3% 12.9% 13.4% 13.2% 12.9% 12.2% 12.1% 12.6% 12.5% 10.6% 10.7% 10.3% 10.2% 9.8% 9.4% 9.2% 9.1% 9.2% 9.2% 9.2% 8.9% 9.3% 9.6% 9.8% 5% 10% 15% 20% Q2-14 Q3-14 Q4-14 Q1-15 Q2-15 Q3-15 Q4-15 Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17 GAAP Effective Yield Core Yield Loan Coupon Rate
$88.6 $38.7 $84.0 $146.7 $46.5 $47.3 $189.2 $105.5 $55.0 $117.6 $84.2 $67.2 $100.3 $166.4 $114.7 $124.2
10.9% 4.2% 9.0% 15.4% 4.3% 4.0% 17.1% 9.2% 9.4% 9.4% 6.6% 4.9% 7.2% 12.7% 8.7% 8.7%
0% 5% 10% 15% 20% $0 $50 $100 $150 $200 Q1-14 Q2-14 Q3-14 Q4-14 Q1-15 Q2-15 Q3-15 Q4-15 Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17
Early Payoffs Early Payoffs as % of Ending Total Debt Investment Balance at Cost
(2)
$388.5 $324.0 $358.0 $505.6
(1)
(1) Effective Yield is inclusive of all fees, including all realized unamortized fees and all realized transaction fees including but not limited to amendment fees and prepayment fees, and is calculated based on the weighted average principal balance of loans outstanding on a daily basis (2) Core Yield excludes Early Repayments and One-Time Fees, and includes income and fees from expired commitments
$95.3 $104.0 $147.7 $134.1 $159.1 $109.6 $75.4 $64.6 $71.2 $73.9 $59.7 $75.9 $57.6 $46.3 $73.6
10.4% 11.2% 15.5% 12.4% 13.6% 9.9% 6.5% 5.2% 5.7% 5.8% 4.3% 5.4% 4.4% 3.5% 5.1%
$0.0 $30.0 $60.0 $90.0 $120.0 $150.0 $180.0 Q2-14 Q3-14 Q4-14 Q1-15 Q2-15 Q3-15 Q4-15 Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17 0% 2% 4% 6% 8% 10% 12% 14% 16%
Available Unfunded Commitments (in millions) Unfunded Commitments as % of Ending Debt Investment Balance at Cost
Available Unfunded Commitments (in millions) Unfunded Commitments as % of Total Ending Debt Investment Balance at Cost
EFFECTIVE MANAGEMENT OF UNFUNDED COMMITMENTS AS A PERCENTAGE OF ENDING DEBT INVESTMENT PORTFOLIO BALANCE
(1) Amount represents available unfunded commitments, including undrawn revolving facilities, which are available at the request by the portfolio company.
(1)
26
RSU = Restricted Stock Units
27
$6,319 $8,454 $7,414 $9,925 $12,472 $7,559 $8,265 $9,732 $9,736 $10,874 $9,410 $10,667 $9,562 $11,023 2.1% 2.7% 2.3% 3.1% 3.9% 2.3% 2.4% 2.8% 2.8% 3.1% 2.6% 2.9% 2.6% 2.8% $- $2,000 $4,000 $6,000 $8,000 $10,000 $12,000 $14,000 0% 1% 2% 3% 4% 5% 6% 7% 8%
Q3 2014 Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Q4 2016 Q1 2017 Q2 2017 Q3 2017 Q4 2017
OPEX (in thousands) OPEX as a % of Total Assets
OPEX (excluding interest, fees, employee RSU & option expense) OPEX as a % of Average Total Assets
$7,825 $9,142 $11,166 $10,134 $12,193 $14,651 $9,764 $10,836 $11,334 $11,178 $12,301 $11,242 $12,575 $11,393 $12,641
23.0% 24.7% 30.3% 31.2% 32.0% 31.1% 24.8% 27.8% 26.0% 24.8% 22.2% 24.2% 26.0% 24.8% 25.2% 0% 5% 10% 15% 20% 25% 30% 35% Q2-14 Q3-14 Q4-14 Q1-15 Q2-15 Q3-15 Q4-15 Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17 $0 $5,000 $10,000 $15,000 $20,000
Non-Interest OPEX as a % of Total Investment Income Non-Interest OPEX (in thousands)
Non-Interest Expense Non-Interest Expense as a % of Total Investment Income
28
Credit Grading at Fair Value, Q4 2017 - Q4 2016 ($ in millions) Q4 2017 Q3 2017 Q2 2017 Q1 2017 Q4 2016 Grade 1 - High 345.2 $ 24.4% 190.0 $ 14.6% 267.1 $ 20.7% 260.2 $ 19.8% 275.8 $ 20.8% Grade 2 583.0 $ 41.2% 696.2 $ 53.6% 613.7 $ 47.6% 591.7 $ 45.1% 590.5 $ 44.4% Grade 3 443.8 $ 31.3% 370.9 $ 28.5% 315.2 $ 24.5% 356.9 $ 27.2% 329.4 $ 24.8% Grade 4 41.7 $ 2.9% 43.0 $ 3.3% 87.0 $ 6.8% 78.9 $ 6.0% 58.9 $ 4.4% Grade 5 - Low 2.3 $ 0.2%
0.0% 4.6 $ 0.4% 24.2 $ 1.9% 74.2 $ 5.6% Weighted Avg. 2.17 2.24 2.27 2.43 2.41
Steady credit quality rating – no oil & gas or CLO exposure
(1) Debt only; based on fair value
$822.0 $923.9 $1,058.0 $1,137.6 $1,077.6 $1,110.2 $1,205.7 $1,211.8 $1,224.1 $1,224.1 $1,311.9 $1,287.6 $1,300.1 $1,416.0
2.20 2.24 2.26 2.25 2.33 2.16 2.17 2.11 2.32 2.41 2.43 2.27 2.24 2.17
1.0 2.0 3.0 4.0 5.0 $0 $200 $400 $600 $800 $1,000 $1,200 $1,400 Q4-13 Q4-14 Q1-15 Q2-15 Q3-15 Q4-15 Q1-16 Q2-16 Q3-16 Q4-16 Q1-17 Q2-17 Q3-17 Q4-17
Credit Rating Debt Portfolio Value ($ in millions) Debt Portfolio Value Weighted Investment Credit Rating
(1)
High Quality Low Quality
29
Wells Fargo 12.1% Union Bank 7.5% Convertible Notes 23.1% July 2024 Notes 18.4% SBA License 1 - HTII 14.9% SBA License 2 - HTII 4.1% Asset Backed Notes 4.9% 2022 Notes 15.0%
$120.0 $75.0 $230.0 $183.5 $41.2 $149.0 $49.2
($ in millions)
$150.0
30
Entity Capitalization
Capital Source as of 12/31/17 $ in Millions % of Total Equity $841.0 51.2% SBA Debentures $190.2 11.6% Asset-Backed Notes $49.2 3.0% Convertible Notes $230.0 14.0% 2024 Notes (Baby Bonds) $183.5 11.1% 2022 Notes 150.0 9.1% Credit Facilities $0.0 0.0% Total Capital $1,643.9 100.0%
Debt Capital Stack Total Corporate Capitalization
SBA Debentures 11.6% Equity 51.2% Asset-Backed Notes 3.0% Credit Facilities 0.0% Convertible Notes 14.0% 2024 Notes (Baby Bonds) 11.1% 2022 Notes 9.1%
(1) Interest rate range for the SBA debentures does not include annual fees
31
Wells Fargo Credit Facility Union Bank Credit Facility Notes SBA Debentures – Total debt of $190.2 million Securitization January 2022 Convertible Notes October 2022
July 2024 Notes License 1 - HTII License 2- HTIII DATE ENTERED
July 2014
May 2010
FACILITY SIZE
($ in millions)
$120.0 $75.0 $230.0 $150.0 $183.5 $41.2 $149.0 $49.2 INTEREST RATE LIBOR + 325bps LIBOR + 325bps 4.375% unsecured 4.625% Unsecured 6.25% unsecured
Range(1) from 3.2% to 4.6% Range(1) from 2.2% to 4.1%
3.524% MATURITY August 2019 May 2020 February 2022 October 2022 July 2024 Mature ten years after borrowing April 2021 ADDITIONAL INFO (Expandable up to $300.0) (Expandable up to $200.0) S&P: BBB- KBRA: BBB+ S&P: BBB- KBRA: BBB+
NYSE: HTGX S&P: BBB- KBRA: BBB+
Set in March and September (range from 2.2% to 5.5%) Rated A(sf) by Kroll OUTSTANDING
($ in millions)
$0.0 $0.0 $230.0 $150.0 $183.5 $41.2 $149.0 $49.2
Well Managed Debt Maturity Schedule
$49.2 $230.0 $21.8 $29.4 $53.8 $60.5 $24.8 $183.5 $150.0 $0 $100 $200 $300 $400 2018 2019 2020 2021 2022 2023 2024
Securitization Convertible Notes SBA Bonds July 2024 Notes October 2022 Notes
($ in millions)
62.0% Net Regulatory Leverage, excluding SBA and cash 72.9% Regulatory Leverage, excluding SBA
BDC Regulatory Limitation of Debt to Equity Ratio
Potential Max Debt of
Potential Max Debt to Equity Ratio of
Equity – $841.0 Million
Asset-Backed Notes – $49.2 Million Unsecured Notes – $563.5 Million SBIC Debenture – $190.2 Million December 31, 2017
Additional Debt Capacity – $228.3 Million
Credit Facilities 1) Revolving accordion credit facility for up to $300.0 million with Wells Fargo Capital Finance, $120.0 million expanded commitment. 2) Revolving accordion credit facility for up to $200.0 million with Union Bank, $75.0 million initial commitment. SBA Additional Leverage: 1st SBIC license issued in September 2006 by the SBA, 2nd SBIC license issued in May 2010 by the SBA. SEC exemptive order approved on April 5, 2007 rendering SBA licensees not subject to BDC 1:1 leverage restrictions. Leverage ratios determined using Principal Amount of Debt 32
34
0.4% 1.3% 5.9% 23.9% 7.7% 4.7% 1.6% 10.0% 9.9% 6.1% 0.7% 23.4% 2.4% 1.0% 0.6% 0.4% Communications & Networking Consumer & Business Products Drug Delivery Drug Discovery & Development Sustainable & Renewable Technologies Healthcare Services, Other Information Services Internet Consumer & Business Services Media/Content/Info Medical Devices & Equipment Semiconductors Software Specialty Pharmaceuticals Diagnostic & Surgical Devices Electronics & Computer Hardware Biotechnology Tools
96.4% 3.6% Floating Fixed 73.2% 18.6% 5.8% 2.4% First Lien Second LIen Equity Investments Warrant Positions
Floating vs. Fixed Rate Investment Type Breakout Industry Breakout Hercules Investments by Geography 42% 11% 3% 38% 4% International: 6%
Two (2) Existing Portfolio Companies in IPO Registration – Q4 2017
▪ Quanterix Corp., Aquantia Corp. and ForeScout Technologies, Inc. complete IPOs ▪ Two (2) companies filed confidentially under the JOBS Act
Nineteen (19) Announced or Completed Portfolio Company M&A Liquidity Events – 2017 Current Warrant and Equity Portfolio – Q4 2017
HERCULES WARRANT & EQUITY PORTFOLIO: POTENTIAL FUTURE UPSIDE FOR SHAREHOLDERS TOTAL RETURN
▪ 137 warrant holdings
▪ 52 equity holdings
35
▪ Illustrative models of potential warrant gains (as of 12/31/17)
$43.8M x 2X multiple: $87.6M - $43.6M cost = $44.0M unrealized gain = $0.52/share $43.8M x 3X multiple: $131.4M - $43.6M = $87.8M unrealized gain = $1.05/share $43.8M x 4X multiple: $175.2M - $43.6M = $131.6M unrealized gain = $1.57/share
36
Technology Life Sciences Sustainable & Renewable Technology Special Situations
36
* Equity-only Investments
* * *
24.1% 26.2% 23.7% 29.7% 23.9% 2.2% 5.1% 4.3% 2.7% 2.4% 11.4% 13.5% 7.5% 7.6% 6.1% 4.0% 6.0% 2.8% 1.3% 0.4% 5.2% 2.6% 6.8% 8.7% 13.7% 7.7% 5.9% 13.4% 6.8% 7.4% 6.8% 10.0% 2.9% 9.7% 9.9% 7.2% 12.3% 12.3% 15.4% 23.4% 18.1% 6.7% 13.3% 10.9% 7.7% 1.5% 2.0%
6.2%
3.0% 1.3%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2013 2014 2015 2016 2017 % Total Investment Portfolio at Fair Value
Electronics & Computer Hardware Consumer & Business Products Diagnostic & Surgical Device Healthcare Services, Other Sustainable & Renewable Software Semiconductors Media/Content/Info Internet Consumer & Business Services Drug Delivery Information Services Communications & Networking Medical Devices & Equipment Specialty Pharmaceuticals Drug Discovery & Development Biotechnology Tools
$910.3 $1,020.7 $1,200.6
($M)
$1,423.9
A BROADLY DIVERSIFIED PORTFOLIO RE-BALANCED ACCORDING TO OUR ASSESSMENT OF ONGOING MARKET CONDITIONS MITIGATES RISK
37
8.0% 4.0%
$1,542.2
4.7%
More than 1000 Venture Capital Firms & Investors Technology Life Sciences Sustainable & Renewable Special Situations Expansion or “Venture Growth” & Established Key VC Investment Centers
Palo Alto Boston New York Washington DC Chicago Hartford
FINANCIAL SPONSORS INDUSTRY SECTORS STAGES OF DEVELOPMENT GEOGRAPHIC LOCATION
Four Key Diversification Strategies
38
$13.1
$17.9
$49.5 $94.1 $36.8 $22.6 $20.3 $23.6 $25.1 $31.2 $34.5 $33.3 $25.2 $28.9 $36.7 $34.8 $36.4 $58.5 $73.4 $50.5 $64.9
2,211 2,547 4,590 6,350 3,341 2,484 2,294 2,462 2,633 2,892 3,155 3,123 2,799 3,204 3,729 3,906 4,048 4,278 4,115 3,718 3,461
1,000 2,000 3,000 4,000 5,000 6,000 7,000 $0 $10 $20 $30 $40 $50 $60 $70 $80 $90 $100 97 98 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 # of Deals Dollars Invested (billions) $ in billions # of deals
Venture Capital Investment Activity 1997 – Q4 2017
Source: Dow Jones VentureSource Q4 2017 40
$26.9 $54.6 $85.5 $42.5 $12.5 $10.4 $18.9 $29.0 $31.9 $39.3 $29.8 $14.9 $17.9 $21.5 $23.3 $21.7 $35.5 $37.6 $44.1 $36.9 $0 $10 $20 $30 $40 $50 $60 $70 $80 $90 98 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 Funds Raised (billions)
Venture Capital Fundraising Activity 1997 – Q4 2017
0% 20% 40% 60% 80% 100% 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
IPOs M&A
2.0 2.8 3.8 4.6 5.4 6.0 6.5 5.8 5.5 5.3 5.3
5.2
5.0 5.0 4.7 5.2 4.9 4.5 6.5 5.7 5.6 5.6 6.2 6.8 8.7 7.9 8.1 6.4 7.3 6.8 7.1 6.7 7.2 7.5
2 4 6 8 10 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
IPOs M&A
Venture Debt Complements Equity Financing and Optimizes Capital Structure
41
As Time to Exit has Increased... … M&A Remains the Exit of Choice
Less dilutive than new VC round
Lengthens time before next equity round
Provides negotiating leverage for higher valuations
Leverages returns
Source: Dow Jones VentureSource Q4 2017
Median Time from Initial Equity Funding Breakdown of Venture Backed Liquidity Events
Source: Dow Jones VentureSource Q4 2017
$0.6 $0.9 $3.3 $5.4 $11.2 $8.3 $9.4 $6.5 $2.9 $8.3 9 8 48 47 51 76 108 70 38 57 20 40 60 80 100 120 $0 $2 $4 $6 $8 $10 $12
08 09 10 11 12 13 14 15 16 17
# of IPOs Amount Raised (billions)
$ in billions # of IPOs $26.5 $22.8
$44.8 $50.2 $45.0 $43.9 $86.6 $53.3 $88.0 $76.4 456 440 612 603 538 533 601 560 613 600 100 200 300 400 500 600 700 800 $0 $20 $40 $60 $80 $100
08 09 10 11 12 13 14 15 16 17
# of Deals Amount Paid (billions)
$ in billions # M&A Deals
Source: Dow Jones VentureSource Q4 2017 42
Mergers & Acquisitions Initial Public Offerings
Commitments as % of VC Dollars Invested
0.9% 0.8% 1.4% 1.2% 0.8% 1.8% 1.7% 1.8% 1.9% 1.6% 1.0% 1.6% 1.4%
VENTURE CAPITAL INVESTMENT ACTIVITY 2005 –Q4 2017
Source: Dow Jones VentureSource Q4 2017
▪ Hercules’ uncompromising yield and credit underwriting standards drives commitments ▪ Market conditions determine commitment activity more than pure VC investment activity ▪ Hercules’ 13-year historical average: 1.4%
43
$25.1 $31.2 $34.5 $33.3 $25.2 $28.9 $36.7 $34.8 $36.4 $58.5 $73.4 $50.5 $64.9 $215 $243 $494 $413 $186 $523 $630 $637 $705 $905 $745 $807 $882
$0 $10 $20 $30 $40 $50 $60 $70 $80 05 06 07 08 09 10 11 12 13 14 15 16 17 $0 $100 $200 $300 $400 $500 $600 $700 $800 $900 $1,000
VC Dollars Invested (billions) Hercules Debt and Equity Commitments (millions) VC Dollars Invested Hercules Debt & Equity Commitments
Source: Dow Jones VentureSource Q4 2017 44
48 47 51 76 108 70 38 2 2 7 5 8 7 1 3 1 2 3 4 5 6 7 8 9 20 40 60 80 100 120
10 11 12 13 14 15 16 17
Hercules’ Portfolio Company IPOs Venture Backed IPOs
VC-backed IPOs Hercules' PoCo IPOs
Participation as % of Total VC-Backed IPOs
4% 4% 14% 7% 7% 10% 3% 5% PROVIDING INVESTOR ACCESS TO SOME OF AMERICA’S MOST PROMISING COMPANIES
▪ M&A represents on average 91% of venture capital investment exits since 2010
57
45
Large Market Opportunity Attractive Yields and Equity Upside from Warrant Portfolio Focused on strong and sustainable shareholder returns Experienced Management Team Platform in Place to Grow Portfolio Strong Balance Sheet and Diverse Funding Sources Strong Venture Capital and Private Equity Relationships Strict Focus on Credit Underwriting Process
47
Jonathan Bock (Initiated Coverage 4/25/2011) Ryan Lynch (Re-initiated Coverage 2/19/2013) Jason Arnold (Initiated Coverage 12/14/2007) Robert Dodd (Initiated Coverage 7/26/2012) Aaron James Deer (Initiated Coverage 9/29/2011) John Hecht (Initiated Coverage 6/30/2015) Casey Alexander (Initiated Coverage 6/23/15) Mitchel Penn (Initiated Coverage 1/14/2015) Chris York (Initiated Coverage 10/24/2012) Tim Hayes (Re-initiated Coverage 10/2/2017) Henry Coffey (Initiated Coverage 10/24/17) Christopher Nolan (Initiated Coverage 11/20/2017)
Business Development Company (BDC)
▪ Regulated by the SEC under the Investment Company Act of 1940 ▪ Leverage limited to approximately 1:1 debt/equity, unless an SEC exemptive order exists to exclude SBA
debt
▪ Investments are required to be carried at fair value ▪ Majority of Board of Directors must be independent ▪ Offer managerial assistance to portfolio companies
Regulated Investment Company (RIC)
▪ Distribute taxable income as dividends to shareholders ▪ Mandates asset diversification ▪ Eliminates corporate taxation ▪ Allows for the retention of capital gains and/or spillover of taxable income
Small Business Investment Company (SBIC)
▪ Two Small Business Investment Company (“SBIC”) licenses granted through the U.S. Small Business
Administration (“SBA”)
▪ Currently, $190.2 million exemption from SEC leverage restrictions for BDCs, excludes all SBIC debt from
BDC 1:1 leverage test
Hercules is an Internally Managed BDC under the 1940 Act and a RIC for Tax Purposes
49
▪ Rapidly amortizing principal balance
and current cash-pay interest
▪ “Security interest” – generally first
security interest in all assets of borrower
▪ Simultaneous or recent equity round;
in addition sponsor commitment for continued financial support
▪ Generally expect sufficient capital at
time of investment to support
9 -18 months
▪ Diversification across industry
sub-sectors, development stages and financial sponsors
50
Note: Capital at risk reduced by fees, principal payments and interest payments. Assumes 36 month term, 1% origination fee, 11% interest, and a level payment schedule.
Reduction of Invested Capital at Risk
94% 71% 48% 25% 79% 60% 40% 20% 99% 0% 20% 40% 60% 80% 100% 3 6 9 12 15 18 21 24 27 30 33 36 Term of Loan (Months) % of Remaining HTGC's Capital at Risk Level Payment w/ 6-mo I/O Level Payment
Nearly 1/3 of invested capital returned in 12-months
51
Expansion Stage Established
Type of Company
Follow-on Rounds
(Series B-Liquidity Event) Private Late Stage/ Select Public Companies
Equity Capital Provider
Venture Capital/ Private Equity Public Markets/ Private Equity
Expectation for Additional Sponsor Support
1–3 Additional Rounds 0–2 Additional Rounds
Targeted Warrant Gain Potential
3–7 x 2–4 x
Potential Time to Liquidity
4–6 years 2–4 years